Impact of advance directives on the ...
Document type :
Article dans une revue scientifique: Article original
PMID :
Permalink :
Title :
Impact of advance directives on the variability between intensivists in the decisions to forgo life-sustaining treatment
Author(s) :
Smirdec, Margot [Auteur]
Jourdain, Mercedes [Auteur]
Recherche translationnelle sur le diabète (RTD) - U1190
Guastella, Virginie [Auteur]
Lambert, Céline [Auteur]
Richard, Jean-Christophe [Auteur]
Argaud, Laurent [Auteur]
Jaber, Samir [Auteur]
Klouche, Kada [Auteur]
Medard, Anne [Auteur]
Reignier, Jean [Auteur]
Rigaud, Jean-Philippe [Auteur]
Doise, Jean-Marc [Auteur]
Chabanne, Russell [Auteur]
Souweine, Bertrand [Auteur]
Bourenne, Jeremy [Auteur]
Delmas, Julie [Auteur]
Bertrand, Pierre-Marie [Auteur]
Verdier, Philippe [Auteur]
Quenot, Jean-Pierre [Auteur]
Aubron, Cécile [Auteur]
Eisenmann, Nathanael [Auteur]
Asfar, Pierre [Auteur]
Fratani, Alexandre [Auteur]
Dellamonica, Jean [Auteur]
Terzi, Nicolas [Auteur]
Constantin, Jean-Michel [Auteur]
Van Lander, Axelle [Auteur]
Guerin, Renaud [Auteur]
Pereira, Bruno [Auteur]
Lautrette, Alexandre [Auteur]
Jourdain, Mercedes [Auteur]

Recherche translationnelle sur le diabète (RTD) - U1190
Guastella, Virginie [Auteur]
Lambert, Céline [Auteur]
Richard, Jean-Christophe [Auteur]
Argaud, Laurent [Auteur]
Jaber, Samir [Auteur]
Klouche, Kada [Auteur]
Medard, Anne [Auteur]
Reignier, Jean [Auteur]
Rigaud, Jean-Philippe [Auteur]
Doise, Jean-Marc [Auteur]
Chabanne, Russell [Auteur]
Souweine, Bertrand [Auteur]
Bourenne, Jeremy [Auteur]
Delmas, Julie [Auteur]
Bertrand, Pierre-Marie [Auteur]
Verdier, Philippe [Auteur]
Quenot, Jean-Pierre [Auteur]
Aubron, Cécile [Auteur]
Eisenmann, Nathanael [Auteur]
Asfar, Pierre [Auteur]
Fratani, Alexandre [Auteur]
Dellamonica, Jean [Auteur]
Terzi, Nicolas [Auteur]
Constantin, Jean-Michel [Auteur]
Van Lander, Axelle [Auteur]
Guerin, Renaud [Auteur]
Pereira, Bruno [Auteur]
Lautrette, Alexandre [Auteur]
Journal title :
Critical Care
Abbreviated title :
Crit Care
Volume number :
24
Pages :
672
Publisher :
BioMed Central
Publication date :
2020-12-02
ISSN :
1466-609X
English keyword(s) :
Advance directives
Decisions to forgo life-sustaining treatment
ICU
Decisions to forgo life-sustaining treatment
ICU
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Background
There is wide variability between intensivists in the decisions to forgo life-sustaining treatment (DFLST). Advance directives (ADs) allow patients to communicate their end-of-life wishes to physicians. We ...
Show more >Background There is wide variability between intensivists in the decisions to forgo life-sustaining treatment (DFLST). Advance directives (ADs) allow patients to communicate their end-of-life wishes to physicians. We assessed whether ADs reduced variability in DFLSTs between intensivists. Methods We conducted a multicenter, prospective, simulation study. Eight patients expressed their wishes in ADs after being informed about DFLSTs by an intensivist-investigator. The participating intensivists answered ten questions about the DFLSTs of each patient in two scenarios, referring to patients’ characteristics without ADs (round 1) and then with (round 2). DFLST score ranged from 0 (no-DFLST) to 10 (DFLST for all questions). The main outcome was variability in DFLSTs between intensivists, expressed as relative standard deviation (RSD). Results A total of 19,680 decisions made by 123 intensivists from 27 ICUs were analyzed. The DFLST score was higher with ADs than without (6.02 95% CI [5.85; 6.19] vs 4.92 95% CI [4.75; 5.10], p < 0.001). High inter-intensivist variability did not change with ADs (RSD: 0.56 (round 1) vs 0.46 (round 2), p = 0.84). Inter-intensivist agreement on DFLSTs was weak with ADs (intra-class correlation coefficient: 0.28). No factor associated with DFLSTs was identified. A qualitative analysis of ADs showed focus on end-of-life wills, unwanted things and fear of pain. Conclusions ADs increased the DFLST rate but did not reduce variability between the intensivists. In the decision-making process using ADs, the intensivist’s decision took priority. Further research is needed to improve the matching of the physicians’ decision with the patient’s wishes. Trial registration ClinicalTrials.gov Identifier: NCT03013530. Registered 6 January 2017; https://clinicaltrials.gov/ct2/show/NCT03013530.Show less >
Show more >Background There is wide variability between intensivists in the decisions to forgo life-sustaining treatment (DFLST). Advance directives (ADs) allow patients to communicate their end-of-life wishes to physicians. We assessed whether ADs reduced variability in DFLSTs between intensivists. Methods We conducted a multicenter, prospective, simulation study. Eight patients expressed their wishes in ADs after being informed about DFLSTs by an intensivist-investigator. The participating intensivists answered ten questions about the DFLSTs of each patient in two scenarios, referring to patients’ characteristics without ADs (round 1) and then with (round 2). DFLST score ranged from 0 (no-DFLST) to 10 (DFLST for all questions). The main outcome was variability in DFLSTs between intensivists, expressed as relative standard deviation (RSD). Results A total of 19,680 decisions made by 123 intensivists from 27 ICUs were analyzed. The DFLST score was higher with ADs than without (6.02 95% CI [5.85; 6.19] vs 4.92 95% CI [4.75; 5.10], p < 0.001). High inter-intensivist variability did not change with ADs (RSD: 0.56 (round 1) vs 0.46 (round 2), p = 0.84). Inter-intensivist agreement on DFLSTs was weak with ADs (intra-class correlation coefficient: 0.28). No factor associated with DFLSTs was identified. A qualitative analysis of ADs showed focus on end-of-life wills, unwanted things and fear of pain. Conclusions ADs increased the DFLST rate but did not reduce variability between the intensivists. In the decision-making process using ADs, the intensivist’s decision took priority. Further research is needed to improve the matching of the physicians’ decision with the patient’s wishes. Trial registration ClinicalTrials.gov Identifier: NCT03013530. Registered 6 January 2017; https://clinicaltrials.gov/ct2/show/NCT03013530.Show less >
Language :
Anglais
Peer reviewed article :
Oui
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Collections :
Submission date :
2024-01-19T23:17:29Z
2024-09-17T13:12:28Z
2024-09-17T13:12:28Z
Files
- s13054-020-03402-7-1.pdf
- Version éditeur
- Open access
- Access the document